| 2004N-0181 - Critical Path Initiative; Establishment of Docket | |||||||||||||||||||||||
| FDA Comment Number : | EC31 | ||||||||||||||||||||||
| Submitter : | Dr. Bess Dawson-Hughes | Date & Time: | 08/02/2004 07:08:05 | ||||||||||||||||||||
| Organization : | National Osteoporosis | ||||||||||||||||||||||
| Health Care Association | |||||||||||||||||||||||
| Category : | |||||||||||||||||||||||
| Issue Areas/Comments | |||||||||||||||||||||||
| GENERAL | |||||||||||||||||||||||
| GENERAL | |||||||||||||||||||||||
| Pursuant to comments sent to the docket by the National Osteoporosis Foundation and the American Society for Bone and Mineral Research, the American Society for Bone and Mineral Research is no longer a signatory to these comments. The National Osteoporosis Foundation has resubmitted the comments on its own. | |||||||||||||||||||||||